Core Viewpoint - DXS International plc has provided an update regarding a cyber security incident that affected its office servers, confirming that the situation has been contained and additional security measures are being implemented to enhance monitoring and protection [2]. Group 1: Incident Update - The cyber security incident was reported on December 18 and has since been contained [2]. - The company is taking proactive steps by implementing additional monitoring and security measures to ensure ongoing vigilance [2]. Group 2: Company Overview - DXS International plc operates in the healthcare information sector, providing digital clinical decision support systems [2]. - The company delivers up-to-date treatment guidelines and recommendations from trusted NHS sources to healthcare professionals, aiming to improve healthcare outcomes and contribute to NHS efficiency savings [4].

Core Points - DXS International plc announced that all resolutions at the Annual General Meeting (AGM) were passed successfully [2][3] - The CEO, David Immelman, provided an update on the company's progress during the AGM [3] Voting Results - Resolution 1: 14,681,963 votes for (100.00%), 0 votes against [3] - Resolution 2: 14,647,713 votes for (99.77%), 34,250 votes against (0.23%) [3] - Resolution 3: 14,671,963 votes for (99.97%), 5,000 votes against (0.03%) [3] - Resolution 4: 14,671,963 votes for (99.97%), 5,000 votes against (0.03%) [3] - Resolution 5: 14,676,963 votes for (99.97%), 5,000 votes against (0.03%) [3] - Resolution 6: 14,671,963 votes for (99.97%), 5,000 votes against (0.03%) [3] Company Overview - DXS International provides healthcare information and digital clinical decision support systems, aiming to improve healthcare outcomes and contribute to NHS efficiency savings [4]

Core Viewpoint - DXS International plc has reported a cyber security incident affecting its office servers, which was discovered on December 14. The company is actively managing the situation with minimal impact on its services and does not expect a material adverse effect on its financial position or forecasts for FY 30 April 2026 [2][4][5]. Group 1: Incident Details - The security incident was contained quickly through collaboration between DXS's internal IT security teams and NHS England [3]. - An external cyber security specialist agency has been appointed to investigate the nature and extent of the incident [3]. - The company has notified relevant regulators, authorities, and law enforcement agencies, including the Information Commissioner's Office and various NHS bodies, and is cooperating with their investigations [4]. Group 2: Impact on Operations - There was minimal impact on the company's services, and its front-line clinical services remain operational [4]. - The company does not anticipate that the incident will have a material adverse impact on its financial position or market forecasts for FY 30 April 2026 [5]. Group 3: Company Overview - DXS International provides healthcare information and digital clinical decision support systems, delivering up-to-date treatment guidelines and recommendations to healthcare professionals [7]. - The company's services aim to improve healthcare outcomes cost-effectively, contributing to NHS efficiency savings [7].

Core Points - DXS International plc is scheduled to hold its Annual General Meeting on December 18, 2025, at 11:30 AM [2] - Shareholders can access the Notice of Annual General Meeting, AGM Letter, and the Annual Report for the year ended April 30, 2025, on the company's website [3] - DXS International provides healthcare information and digital clinical decision support systems, aiming to improve healthcare outcomes and contribute to NHS efficiency savings [4]

Core Points - DXS International plc's Chairman, Mr. Bob Sutcliffe, purchased 50,000 Ordinary Shares at a price of 1.30p per share on 11 November 2025 [1][3] - Following this transaction, Mr. Sutcliffe and his wife hold a total of 1,383,756 Ordinary Shares, representing 2.16% of the company's issued share capital [2] Transaction Details - The transaction involved the purchase of Ordinary Shares with a nominal value of 0.33p each [3] - The transaction took place on the Aquis Stock Exchange [3] Company Overview - DXS International provides clinical decision support systems that deliver up-to-date treatment guidelines and recommendations from trusted NHS sources to healthcare professionals [4] - The company's solutions aim to improve healthcare outcomes while contributing to the NHS's efficiency savings [4]

Core Viewpoint - DXS International plc has granted share options and warrants to directors, employees, and consultants to align their interests with shareholders and incentivize performance [2][3][5]. Share Options - A total of 6,150,000 share options have been granted under the Enterprise Management Incentive (EMI) scheme, with an exercise price of 8p per share [3]. - Of the EMI options, 3,900,000 replace expired Directors' Share Options with no performance conditions or vesting periods [3]. - An additional 2,250,000 EMI options have a 2-year vesting period, with one third vesting on grant, one third on the anniversary, and the final third on the second anniversary [3][4]. Non-Tax Advantaged Options - 1,220,000 options have been granted under a non-tax advantaged option scheme, also with a 2-year vesting period structured similarly to the EMI options [4]. Warrants - The Board has replaced 1,341,402 expired warrants with new warrants at an exercise price of 4p per share, matching existing advisor warrants [5]. - Additionally, 150,000 new advisor warrants have been issued at an exercise price of 8p per share, with all new warrants having a 5-year exercise period from the grant date [5]. Company Overview - DXS International provides clinical decision support systems that deliver up-to-date treatment guidelines to healthcare professionals, aiming to improve healthcare outcomes and contribute to NHS efficiency savings [7].